MLC Dx | GenomeWeb

MLC Dx

Companies developing DNA sequencing and related technologies, as well as firms working on sequencing-based genetic tests, were among almost 3,000 small biotechs who received a total of $1 billion in grants and tax credits under the QTDP program.

People in the News

Premium

Norrie Russell, Thomas Willis, Malek Faham

Company executives have a patent pending that describes methods “for using DNA sequencing to identify personalized biomarkers in patients with autoimmune disease and other conditions,” according to the recently published patent application.

Paired Ends

Premium

Thomas Willis, Malek Faham, Lawrence Tabak

The molecular diagnostics firm currently has a patent application for a method of using DNA sequencing technology for identifying biomarkers of autoimmune disease.

Researchers at Affymetrix, Genentech, and Stanford University's Genome Technology Center have created a new array-based resequencing assay that they claim is scalable enough to compete with second-generation sequencing platforms.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.